BIIB-095
- Generic Name
- BIIB-095
Pharmacodynamic Study of BIIB095 and BIIB074 in Healthy Participants and Participants With Painful Diabetic Polyneuropathy
Phase 1
Withdrawn
- Conditions
- Healthy VolunteersDiabetic Neuropathies
- Interventions
- First Posted Date
- 2019-09-26
- Last Posted Date
- 2021-03-22
- Lead Sponsor
- Biogen
- Registration Number
- NCT04106050
Evaluating the Safety, Tolerability, and Pharmacokinetics of BIIB095 in Healthy Participants
- First Posted Date
- 2018-03-05
- Last Posted Date
- 2019-05-16
- Lead Sponsor
- Biogen
- Target Recruit Count
- 80
- Registration Number
- NCT03454126
- Locations
- 🇬🇧
Hammersmith Medicines Research, London, United Kingdom
🇬🇧Research Site, Leeds, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath